Introduction
Residual renal function (RRF) correlates with survival in peritoneal dialysis (PD) patients [1] . In contrast, increas- ing peritoneal small-solute clearance has a neutral effect on outcome [2] . Thus, RRF seems to be physiologically more important than peritoneal clearance for patient outcome. The involved mechanisms are poorly understood. Considering the impact of oxidative stress (OS) on cardiovascular mortality in PD patients [3] , we hypothesized that low RRF is associated with higher OS.
Methods
We enrolled 23 stable PD patients without any active infection. The patients' characteristics are summarized in Table 1 .
Peritoneal adequacy
The total weekly urea Kt/V and the normalized protein catabolic rate (nPCR) were assessed from the 24-h peritoneal effluent and urine collection (PD Adequest: Baxter Healthcare Corporation, McGaw Park, IL, USA). The contribution of total weekly urea Kt/V (total Kt/V) by PD (Kt/V PD) and RRF (KRU) were estimated separately. The peritoneal permeability was assessed by a peritoneal equilibration test.
Blood measurements
A blood sample was collected after an overnight fast for the analysis of serum concentration of urea, creatinine, albumin, pre-albumin and CRP by routine laboratory methods. Total and free malondialdehydes (MDA) were measured by LC-MS, and lipid hydroperoxides (LHP) by an automated method, as previously described [4] [5] [6] .
Statistical analysis
Continuous variables are reported as mean ± SD and compared using the Mann-Whitney U-test. Markers of OS and the dialysis vintage were normally distributed after log transformation and correlations were tested using the Pearson coefficient. Multivariate analysis was performed using multiple linear regressions with log-transformed levels of OS markers. A P-value <0.05 was considered statistically significant. Analysis was performed using SPSS v.13.0.0 (SPSS Inc., Chicago, IL, USA).
Results

Impact of demographic variables and inflammatory or nutritional status
Women had greater total MDA levels compared to men, and tended to have higher levels of free MDA (Table 2) . Diabetes was not a significant determinant of OS (data not shown). Patients on statins or angiotensin-converting enzyme inhibitors or angiotensin receptor blockers were not found to have a lower level of OS (data not shown). Subjects with a CRP level ≥4 mg/L had a higher level of LHP (P = 0.017). Free MDA level decreased with nPCR (Table 3) . No significant correlation was found with albumin and pre-albumin nor with BMI, for any OS marker (data not shown).
Impact of PD related factors
Free MDA and LHP levels decreased with total Kt/V and KRU (Table 3 , Figures 1A , B and 2A, B), but not with Kt/V PD ( Figures 1C and 2C ). Total MDA levels only tended to decrease with KRU. The levels of total MDA and LHP tended to increase with dialysis vintage (Table 3) , which also correlated with KRU (r = −0.58, P = 0.016). The levels of OS markers did not differ between patients on continuous ambulatory or automated PD (data not shown). High or high-average transporters had higher levels of free MDA and LHP in comparison to low-average transporters (149.2 ± 44.1 versus 114.7 ± 15.2 nM, P = 0.053 and 72.1 ± 14.2 versus 59.9 ± 4.4 µM, P = 0.053, respectively). No correlation was found between OS markers and the dialysate protein loss (data not shown). The weekly glucose exposure did not correlate with the OS level (data not shown).
In the multivariate analysis, total Kt/V and KRU remained significantly associated with free MDA after adjustment for gender, nPCR and peritoneal permeability (Table 4) . Total Kt/V and KRU remained significantly associated with LHP after adjustment for a high level of CRP, and peritoneal permeability (Table 5) . After adjustment for total KT/V or KRU, a high peritoneal permeability status was no longer significantly associated with the levels of OS (Tables 4 and 5 ).
Discussion
The main finding of this study is the significant association between RRF and serum levels of lipid peroxidation products, independently of gender, nutritional or inflammatory Total Kt/V, total weekly Kt/V urea; KRU, urinary Kt/V; Kt/V PD, peritoneal Kt/V; nPCR, normalized protein catabolic rate; high permeability, high and high-average peritoneal transporters. The dependent variable (free MDA) was log-transformed to obtain a normal distribution. Exponential transformation of β coefficients (Exp β) implies an interpretation on a multiplicative scale. The level of free MDA changes by 100 * (Exp β)% for one unit increases in dialysis adequacy parameters, nPCR, female gender, or to be high or high-average transporter. status, and peritoneal permeability. Surprisingly, OS was related only to RRF, and not to the peritoneal clearance. To our knowledge, this is the first study showing an inverse association between OS and RRF in PD patients. Considering that advanced glycation end-products (AGEs) correlate with plasma levels of OS [7] , our results are in agreement with earlier findings of an inverse relation between RRF and AGEs in PD [8] . In this latter study, there was no association between MDA level and RRF, but lipid peroxidation was assessed only by measuring total MDA. Total Kt/V, total weekly Kt/V urea; KRU, urinary Kt/V; Kt/V PD, peritoneal Kt/V; high CRP, plasma CRP level ≥ 4 mg/L; high permeability, high and high-average peritoneal transporters. The dependent variable (LHP) was log-transformed to obtain a normal distribution. Exponential transformation of β coefficients (Exp β) implies an interpretation on a multiplicative scale. The level of LHP changes by 100 * (Exp β)% for one unit increases in dialysis adequacy parameters, or female gender, to have a higher CRP level, or to be high or high-average transporter.
RRF is of clinical relevance in PD because it is associated with better survival [1, 2, 9, 10] . However, specific underlying mechanisms are still poorly understood. Low OS could explain this better survival. Indeed, OS is associated with endothelial dysfunction [11] , atherosclerosis [12, 13] , malnutrition [13] and cardiovascular mortality [3] .
How can we explain the association between the decline in RRF and increased levels of OS? Mechanisms explaining increased OS in chronic renal failure may be largely involved. Indeed, high levels of reactive carbonyl compounds (RCO) and AGEs have been described as a state of carbonyl stress in uraemia [14] . Both an increased generation and a reduced removal may contribute to this accumulation of RCO. Nevertheless, the relation between preserved RRF and lower OS could just be a marker of comorbidities. Indeed, factors contributing to an increase in OS include characteristics (such as diabetes [15] , malnutrition [16] and inflammation [17, 18] ) also associated with an impaired RRF. However, the multivariate analysis does not support this hypothesis.
Considering that renal clearance might be the main mechanism leading to lower levels of OS markers in the case of preserved RRF, why then can PD not counteract this phenomenon? The initiation of PD leads to a decrease in levels of advanced oxidation protein products among nondiabetic patients [19] , but without any correlation with peritoneal clearance [19] . A part of OS products might only be cleared by the kidney and not by PD [20] . Considering the high molecular weight of the protein-bound MDA, the total MDA is, as expected, not correlated with the peritoneal clearance in our study. In contrast, the free MDA could be cleared by PD, considering its low molecular weight (72 Da).
The elimination of OS compounds could be compensated by the OS generated by PD itself. Indeed, the initiation of PD is followed by an increase in AGE levels [19] and there is an increase in furosine content of plasma proteins within the time frame of the peritoneal equilibration test [21] . AGE formation can result from an accumulation of glucose degradation products [14, 22] derived from the sterilization of conventional PD fluids. And the interaction between AGEs and their cellular receptor is a source of OS [23] . The higher levels of OS found in high transporters could be due to greater fluid reabsorption. A better nutritional status is less likely involved, considering the absence of association between the levels of albumin and OS markers.
Whether increased OS is due to reduced renal function or PD itself, it is conceivable that an overproduction, rather than an accumulation of OS compounds, is involved. Indeed, a reduced RRF is associated with higher levels of free MDA, but not of total MDA.
Several limitations of this study must be mentioned. First, the cross-sectional design does not allow us to assess causality. We cannot conclude whether the decline in RRF causes the increase in OS markers or vice versa. Additional prospective studies should be designed to clarify these hypotheses. The small number of subjects did not allow us to integrate all potential sources of confounding into the multivariate models, such as time on dialysis, and type of PD fluids. Nevertheless, the use of LC-MS, a highly specific technique for MDA measurement, and the separate measurement of free MDA, are the first step to better understand the underlying mechanisms.
In summary, we found that a preserved RRF is associated with lower levels of OS markers in stable PD patients. This could be one way of explaining the better survival of patients with preserved RRF.
